CIK 0001898416 · Biological Products, (No Diagnostic Substances) (SIC 2836) · Nasdaq, Nasdaq · incorporated in N4 · fiscal year ends 12/31
| Filed | Form | Description | Period |
|---|---|---|---|
| 2026-10-20 | 6-K | FORM 6-K | 2026-10-20 |
| 2026-10-14 | 6-K | FORM 6-K | 2026-10-14 |
| 2026-10-07 | 6-K | FORM 6-K | 2026-10-06 |
| 2026-10-05 | 6-K | FORM 6-K | 2026-10-05 |
| 2026-08-31 | 6-K | FORM 6-K | 2026-08-31 |
| 2026-08-21 | 6-K | FORM 6-K | 2026-08-21 |
| 2026-08-19 | 6-K | 6-K | 2026-06-30 |
| 2026-07-29 | 6-K | FORM 6-K | 2026-07-29 |
| 2026-07-01 | 6-K | FORM 6-K | 2026-07-01 |
| 2026-06-30 | SCHEDULE 13D/A | SCHEDULE 13D/A | |
| 2026-06-18 | 6-K | FORM 6-K | 2026-06-18 |
| 2026-06-17 | 6-K | 6-K | 2026-06-16 |
| 2026-06-16 | 424B5 | 424B5 | |
| 2026-06-16 | FWP | FWP | |
| 2026-06-15 | FWP | FWP | |
| 2026-06-15 | 424B5 | 424B5 | |
| 2026-06-15 | 6-K | 6-K | 2026-06-15 |
| 2026-06-08 | 6-K | FORM 6-K | 2026-03-31 |
| 2026-06-04 | 6-K | FORM 6-K | 2026-06-04 |
| 2026-05-11 | 6-K | FORM 6-K | 2026-05-11 |
| 2026-05-04 | 6-K | FORM 6-K | 2026-04-30 |
| 2026-03-31 | 20-F | 20-F | 2025-12-31 |
| 2026-03-19 | 6-K | FORM 6-K | 2025-12-31 |
| 2026-03-12 | SCHEDULE 13D/A | SCHEDULE 13D/A | |
| 2026-02-27 | 6-K | FORM 6-K | 2026-02-27 |
Forms on file (last 1,000): 6-K 158, 424B3 38, 425 21, CORRESP 15, UPLOAD 13, EFFECT 8, F-4/A 6, 20-F 5. Source: SEC EDGAR, as filed; this page is public data and not investment advice.
GET https://store.agentexchange.work/gw/filings/company?ticker=ALVO (0.002 USD), /gw/filings/filings?ticker=ALVO&form=8-K, /gw/filings/facts?ticker=ALVO&concept=Revenues, full-text /gw/filings/search?q=.... Pay per call in USDC (x402) or with a 19 USD card key for 1,000 calls. Catalogue · llms.txtUpdated from EDGAR within 30 minutes of a filing. Agent Exchange